Importance Bladder cancer is a common malignancy in women and is the fourth most
common malignancy in men. Bladder cancer ranges from unaggressive and usually …

Context During the past decade, several urinary biomarker tests (UBTs) for bladder cancer
have been developed and made commercially available. However, none of these is …

The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis,
evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract …

Bladder cancer ranks among the most common cancers globally. At diagnosis, 75% of
patients have non-muscle-invasive bladder cancer (NMIBC). Patients with low-risk NMIBC …

Bladder cancer is one of the most financially burdensome cancers globally, from its
diagnostic to its terminal stages. The impact it imposes on patients and the medical …

Background Ferroptosis is a newly found non-apoptotic forms of cell death that plays an
important role in tumors. However, the prognostic value of ferroptosis-related genes (FRG) in …

Background Patients with metastatic bladder cancer have very poor prognosis and
predictive biomarkers are urgently needed for early clinical detection and intervention. In this …

Background Treatment options are limited for patients with high-risk non-muscle-invasive
bladder cancer (NMIBC) with disease recurrence after bacillus Calmette–Guérin (BCG) …

Bladder cancer is a common malignant tumor of the urinary system. Despite recent
advances in treatments such as local or systemic immunotherapy, chemotherapy, and …

Background and Objectives: To assess the potential prognostic role of the systemic immune-
inflammation index (SII) in predicting oncological outcomes in a cohort of patients treated …